Dushyantha Jayaweera
- Infectious Diseases top 1%
- Virology top 0.5%
- Epidemiology top 10%
- Emergency Medicine top 2%
- Hepatology top 5%
- Co-authors
- Charles FarthingDavid A. CooperCalvin CohenKiat RuxrungthamPeter RuaneChristine KatlamaRichard HaubrichÉric Lefebvre
- Topics
- HIV/AIDS drug development and treatment (27 papers)HIV Research and Treatment (22 papers)Hepatitis C virus research (19 papers)
- Journals
- The LancetSHILAP Revista de lepidopterologíaACS Nano
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Dushyantha Jayaweera
70 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 132
- Infectious Diseases 1.2k
- Virology 832
- Epidemiology 407
- Emergency Medicine 303
- Hepatology 255
Countries citing papers authored by Dushyantha Jayaweera
This map shows the geographic impact of Dushyantha Jayaweera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dushyantha Jayaweera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dushyantha Jayaweera more than expected).
Fields of papers citing papers by Dushyantha Jayaweera
This network shows the impact of papers produced by Dushyantha Jayaweera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dushyantha Jayaweera. The network helps show where Dushyantha Jayaweera may publish in the future.
Co-authorship network of co-authors of Dushyantha Jayaweera
This figure shows the co-authorship network connecting the top 25 collaborators of Dushyantha Jayaweera. A scholar is included among the top collaborators of Dushyantha Jayaweera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dushyantha Jayaweera. Dushyantha Jayaweera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 49 | |
| 7 | 1 | |
| 8 | 44 | |
| 9 | 46 | |
| 10 | 14 | |
| 11 | 20 | |
| 12 | 6 | |
| 13 | 10 | |
| 14 | 76 | |
| 15 | 18 | |
| 16 | 23 | |
| 17 | 45 | |
| 18 | A Once Daily Efavirenz Based Regimen for Treatment Naïve HIV Subjects: 96 Week Results from the DART II Trial | 1 |
| 19 | 30 | |
| 20 | 17 |
About Dushyantha Jayaweera
Dushyantha Jayaweera is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 73 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (22 papers) and Hepatitis C virus research (19 papers). The work is most often cited by research in Virology (832 citations), Infectious Diseases (1.2k citations) and Hepatology (255 citations). Dushyantha Jayaweera has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Charles Farthing, David A. Cooper, Calvin Cohen, Kiat Ruxrungtham, Peter Ruane, Christine Katlama, Richard Haubrich, Éric Lefebvre, Timothy Wilkin and Jean‐Christophe Goffard. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.